Market Closed

CORT
Corcept Therapeutics Incorporated
$ 72.94
-1.04%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Corcept Therapeutics Incorporated News

Latest Corcept Therapeutics Incorporated Stock News & CORT Headlines

Corcept Therapeutics Incorporated (NASDAQ:CORT) Stock Now Rated “Moderate Buy” by Wall Street Analysts
9 days ago | defenseworld.net
CORT's Q3 Earnings Beat, Higher Product Sales Aid Y/Y Revenues
11 days ago | zacks.com
Corcept Therapeutics Incorporated (CORT) Q3 2026 Earnings Call Transcript
12 days ago | seekingalpha.com
Corcept Therapeutics Q3 Earnings Call Highlights
12 days ago | marketbeat.com
Corcept Therapeutics (CORT) Q3 Earnings and Revenues Surpass Estimates
12 days ago | zacks.com
2026 ADA/EASD Consensus Report Recommends Screening for Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes
a month ago | gurufocus.com
2026 ADA/EASD Consensus Report Recommends Screening for Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes
a month ago | businesswire.com
Can Lifyorli Aid Corcept's Long-Term Growth Prospects Beyond Korlym?
a month ago | zacks.com
Corcept Therapeutics (NASDAQ:CORT) Director Sells $1,148,100.00 in Stock
a month ago | defenseworld.net
Corcept Therapeutics Incorporated $CORT Stock Holdings Cut by First Citizens Bank & Trust Co.
a month ago | defenseworld.net
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

CORT
Corcept Therapeutics Incorporated
$ 72.94
-1.04%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago